These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 31068623)

  • 21. The prognostic and therapeutic implications of circulating tumor cell phenotype detection based on epithelial-mesenchymal transition markers in the first-line chemotherapy of HER2-negative metastatic breast cancer.
    Guan X; Ma F; Li C; Wu S; Hu S; Huang J; Sun X; Wang J; Luo Y; Cai R; Fan Y; Li Q; Chen S; Zhang P; Li Q; Xu B
    Cancer Commun (Lond); 2019 Jan; 39(1):1. PubMed ID: 30606259
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications.
    Zhang Q; Rong Y; Yi K; Huang L; Chen M; Wang F
    Theranostics; 2020; 10(26):12060-12071. PubMed ID: 33204329
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical significance of EpCAM mRNA-positive circulating tumor cells in hepatocellular carcinoma by an optimized negative enrichment and qRT-PCR-based platform.
    Guo W; Yang XR; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang X; Zhou J; Fan J
    Clin Cancer Res; 2014 Sep; 20(18):4794-805. PubMed ID: 25009297
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High Epithelial Cell Adhesion Molecule-Positive Circulating Tumor Cell Count Predicts Poor Survival of Patients with Unresectable Hepatocellular Carcinoma Treated with Transcatheter Arterial Chemoembolization.
    Shen J; Wang WS; Zhu XL; Ni CF
    J Vasc Interv Radiol; 2018 Dec; 29(12):1678-1684. PubMed ID: 30392801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma.
    Kocheise L; Schoenlein M; Behrends B; Joerg V; Casar C; Fruendt TW; Renné T; Heumann A; Li J; Huber S; Lohse AW; Pantel K; Riethdorf S; Wege H; Schulze K; von Felden J
    Sci Rep; 2023 Nov; 13(1):20827. PubMed ID: 38012205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High expression of forkhead box protein C2 is associated with aggressive phenotypes and poor prognosis in clinical hepatocellular carcinoma.
    Shimoda Y; Ubukata Y; Handa T; Yokobori T; Watanabe T; Gantumur D; Hagiwara K; Yamanaka T; Tsukagoshi M; Igarashi T; Watanabe A; Kubo N; Araki K; Harimoto N; Katayama A; Hikino T; Sano T; Ogata K; Kuwano H; Shirabe K; Oyama T
    BMC Cancer; 2018 May; 18(1):597. PubMed ID: 29801468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Circulating tumor cells are associated with poor outcomes in early-stage hepatocellular carcinoma: a prospective study.
    Ha Y; Kim TH; Shim JE; Yoon S; Jun MJ; Cho YH; Lee HC
    Hepatol Int; 2019 Nov; 13(6):726-735. PubMed ID: 31691073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An RNA-based signature enables high specificity detection of circulating tumor cells in hepatocellular carcinoma.
    Kalinich M; Bhan I; Kwan TT; Miyamoto DT; Javaid S; LiCausi JA; Milner JD; Hong X; Goyal L; Sil S; Choz M; Ho U; Kapur R; Muzikansky A; Zhang H; Weitz DA; Sequist LV; Ryan DP; Chung RT; Zhu AX; Isselbacher KJ; Ting DT; Toner M; Maheswaran S; Haber DA
    Proc Natl Acad Sci U S A; 2017 Jan; 114(5):1123-1128. PubMed ID: 28096363
    [TBL] [Abstract][Full Text] [Related]  

  • 29. FoxM1 overexpression promotes epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma.
    Meng FD; Wei JC; Qu K; Wang ZX; Wu QF; Tai MH; Liu HC; Zhang RY; Liu C
    World J Gastroenterol; 2015 Jan; 21(1):196-213. PubMed ID: 25574092
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
    Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
    PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Circulating Tumor Cells with Stem-Like Phenotypes for Diagnosis, Prognosis, and Therapeutic Response Evaluation in Hepatocellular Carcinoma.
    Guo W; Sun YF; Shen MN; Ma XL; Wu J; Zhang CY; Zhou Y; Xu Y; Hu B; Zhang M; Wang G; Chen WQ; Guo L; Lu RQ; Zhou CH; Zhang X; Shi YH; Qiu SJ; Pan BS; Cao Y; Zhou J; Yang XR; Fan J
    Clin Cancer Res; 2018 May; 24(9):2203-2213. PubMed ID: 29374055
    [No Abstract]   [Full Text] [Related]  

  • 32. Epithelial to mesenchymal transition is associated with shorter disease-free survival in hepatocellular carcinoma.
    Yamada S; Okumura N; Wei L; Fuchs BC; Fujii T; Sugimoto H; Nomoto S; Takeda S; Tanabe KK; Kodera Y
    Ann Surg Oncol; 2014 Nov; 21(12):3882-90. PubMed ID: 24833103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Chemokine ligand 20 enhances progression of hepatocellular carcinoma via epithelial-mesenchymal transition.
    Hou KZ; Fu ZQ; Gong H
    World J Gastroenterol; 2015 Jan; 21(2):475-83. PubMed ID: 25593462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Circulating tumor cells detected with a microcavity array predict clinical outcome in hepatocellular carcinoma.
    Takahashi K; Ofuji K; Hiramatsu K; Nosaka T; Naito T; Matsuda H; Endo K; Higuchi M; Ohtani M; Nemoto T; Nakamoto Y
    Cancer Med; 2021 Apr; 10(7):2300-2309. PubMed ID: 33675149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Post-ablation des-gamma-carboxy prothrombin level predicts prognosis in hepatitis B-related hepatocellular carcinoma.
    Lee S; Rhim H; Kim YS; Kang TW; Song KD
    Liver Int; 2016 Apr; 36(4):580-7. PubMed ID: 26503910
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased Expression of Circulating Cancer Stem Cell Markers During the Perioperative Period Predicts Early Recurrence After Curative Resection of Hepatocellular Carcinoma.
    Choi GH; Kim GI; Yoo JE; Na DC; Han DH; Roh YH; Park YN; Choi JS
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1444-52. PubMed ID: 25791790
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A New Cell Block Method for Multiple Immunohistochemical Analysis of Circulating Tumor Cells in Patients with Liver Cancer.
    Nam SJ; Yeo HY; Chang HJ; Kim BH; Hong EK; Park JW
    Cancer Res Treat; 2016 Oct; 48(4):1229-1242. PubMed ID: 27034142
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prediction of recurrence and prognosis in patients with hepatocellular carcinoma after resection by use of CLIP score.
    Zhao WH; Ma ZM; Zhou XR; Feng YZ; Fang BS
    World J Gastroenterol; 2002 Apr; 8(2):237-42. PubMed ID: 11925599
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nomograms for postsurgical extrahepatic recurrence prediction of hepatocellular carcinoma based on presurgical circulating tumor cell status and clinicopathological factors.
    Wei HW; Qin SL; Xu JX; Huang YY; Chen YY; Ma L; Qi LN
    Cancer Med; 2023 Jul; 12(14):15065-15078. PubMed ID: 37337754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
    Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
    World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.